Identifying potentially disruptive biopharmaceutical companies within a sea of less compelling opportunities

The Rapha Capital Mission is to use our unique abilities to identify at the earliest stage, those companies that we believe will go on to profoundly improve peoples’ lives while building great value, from a sea of seemingly indistinguishable, less compelling, opportunities.

Rapha Capital Management is focused on identifying and growing revolutionary ideas in medicine, healthcare and technology before others can see their value.

Rapha Capital Management, LLC, founded in mid-2018, has grown to include 13 managed entities, Rapha Capital Investment I – XIII.

Poseida Therapeutics Logo

Poseida Therapeutics, Inc.

NexImmune Icon

NexImmune, Inc.

Rapha Capital Latest News

NEW POST

November 8, 2021 in IMAGIN Medical, Portfolio, Rapha Capital Management

Imagin Medical Announces Appointment of Kayvon Namvar to Board of Directors and Kevin Slawin, M.D. as Board Chairman

Vancouver, B.C. and Boston, MA, November 8, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) “Imagin” or the “Company”),…
Read More
November 2, 2021 in Arbor Rapha Capital BioHoldings Corp I, Portfolio, Rapha Capital Management

Arbor Rapha Capital Bioholdings Corp. I Announces Closing of $172.5 Million Initial Public Offering

Includes Exercise of Underwriters’ Over-Allotment Option in Full NEW YORK, NY, November 2, 2021 — Arbor Rapha Capital Bioholdings Corp.…
Read More
October 29, 2021 in Arbor Rapha Capital BioHoldings Corp I, Portfolio, Rapha Capital Management

SPACtacular spooky season for Arbor Rapha’s blank check; a $180M Entrada onto Wall Street

SPAC season is back as Arbor Rapha Capital Bioholdings, a blank-check company, lands on the public markets today to raise…
Read More